Non-Hodgkin Lymphoma

News

EC approves mogamulizumab for MF, SS

The European Commission (EC) has granted marketing authorization for mogamulizumab (Poteligeo), a humanized monoclonal antibody directed against...

MD IQ

News

Bortezomib may overcome resistance in WM

Bortezomib may help overcome treatment resistance in patients with Waldenström’s macroglobulinemia (WM) and CXCR4 mutations, according to a new...

News

Combo appears safe, active in rel/ref NHL

The combination of Hu5F9-G4 (5F9) and rituximab was considered safe and produced durable complete responses (CRs) in patients with relapsed or...

Pages